Oluwafemi Efuntoye

Dr. Oluwafemi Efuntoye

University College Hospital Ibadan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Pan African Medical Journal
Verified
Journal Article
Open access
YRYemi Raheem Raji
Yemi Raheem Raji
SASamuel Oluwole Ajayi
Samuel Oluwole Ajayi
OAOlusegun Aminu
Olusegun Aminu
BABusayo Abiola
Busayo Abiola
Oluwafemi EfuntoyeOluwafemi Efuntoye
Oluwafemi Efuntoye
SKSolomon Kadiri
Solomon Kadiri
INTRODUCTION: Vascular access is an important aspect of haemodialysis treatments and determinant of patient outcomes. Arteriovenous (AV) fistula has been described as the preferred haemodialysis vascular access for patients on chronic dialysis. There continues to be a challenge with the creation of AV fistula, due to shortage of vascular surgeons skilled in the AV fistula creation particularly in source limited setting. We described the outcomes of the tunneled internal jugular venous catheters amongst our patients at the University College Hospital (UCH) Ibadan. METHODS: a retrospective study of patients on maintenance haemodialysis at the UCH, Ibadan, we reviewed the records of all patients on chronic dialysis over a period of 5 years. Information obtained include demographics, types and aetiology of renal failure, types of vascular access, observed complications and outcomes. RESULTS: a total number of 147 catheters were inserted during the period under review, 94 were in males while 53 were females. The age range was 18-85 years while the mean age was 46.3 ? 17.2 years. The range and mean duration for Tunneled Dialysis Catheter (TDC) carriage were (30 - 1,440) and 220?185 days respectively. The observed immediate complications of TDCs were failed first attempt 7(4.7%), reactionary haemorrhage 5(3.4%), arrhythmia 3(2.0%), haemothorax 2(1.4%) while death during catheter placement was recorded in 2(1.4%) cases. Catheter related infection was the commonest long-term complications and occurred in 15 cases (10.1%), while being diabetic increased the risk of developing catheter related complications. One tenth of our patients with End Stage Renal Disease on TDC had kidney transplantation while catheter related mortality was 16.3%. CONCLUSION: internal jugular tunneled dialysis catheters despite its shortcomings, has been a safe procedure with good outcomes among our patients on maintenance haemodialysis.

EIEfosa Isibor
Efosa Isibor
KKKehinde Kazeem Kanmodi
Kehinde Kazeem Kanmodi
OAOladimeji Adebayo
Oladimeji Adebayo
OOOlusegun Olaopa
Olusegun Olaopa
MIMartin C Igbokwe
Martin C Igbokwe
BRBabalola Rereloluwa
Babalola Rereloluwa
(1) Background: leadership behaviour is a poorly explored phenomenon among early-career doctors (ECDs). Good leadership is vital in maximising the effective management of patients in a clinical setting. While a good number of studies, though with small sample surveys, have researched the role of leadership in clinical setting quantitatively, qualitative investigations are yet to be done in Nigeria. This study aims to explore the attitudes, skills, and experience of ECDs in Nigeria on issues pertaining to leadership in a medical setting, using a mixed-method approach. (2) Methods: we conducted two sessions of key informant focus group discussion (FGD) that involved 14 ECD leaders in Nigeria, exploring their leadership experience in a clinical setting. Furthermore, we used a self-administered questionnaire to quantitatively survey 474 ECDs from seven Nigerian teaching hospitals to explore their attitudes, skills, and experience on issues pertaining to medical leadership. (3) Results: taking on leadership roles is a common phenomenon (52.7%) among the surveyed ECDs; however, the medical leadership position can be very challenging for ECDs in Nigeria. Despite the fact that many (91.1%) of the surveyed ECDs perceived leadership skills as essential skills needed by a doctr, many (44.1%) of them were yet to be formally trained on medical leadership. About three out of every 10 (23.6%) of surveyed ECDs that have ever held leadership positions in a medical setting experienced major leadership challenges while in such office due to their lack of training on leadership skills. Leadership skill acquisition programmes are highly recommended to become an integral part of medical training programmes in Nigeria. (4) Conclusion: there is a need for a structured leadership skill acquisition programme for ECDs in Nigeria. This programme will help in the robust delivery of highly effective healthcare services in Nigeria, as effective leadership is crucial to patient care services.

13 November 2024 in Indian Journal of Nephrology
Verified
Journal Article
Open access
Oluwafemi EfuntoyeOluwafemi Efuntoye
Oluwafemi Efuntoye
IAIfeoma Faith Agburum
Ifeoma Faith Agburum
JBJyoti Baharani
Jyoti Baharani
VSVinay Sankurshetty
Vinay Sankurshetty
OAOdunayo Ashimolowo
Odunayo Ashimolowo
NKNithya Krishnan
Nithya Krishnan
Background: COVID-19 pandemic significantly affected health services globally, resulting in poorer outcomes, especially in patients with chronic long-term illnesses. For patients with chronic kidney disease (CKD), potential effects might include, among others, disruption of dialysis services, reduced kidney transplant rates, and increased incidence of severe COVID-19 infections and death. Such differences may be further exacerbated in patients from Black, Asian, and Minority Ethnic (BAME) populations with CKD. To conduct a systematic review to identify the global impact of COVID-19 on kidney replacement therapy and to determine the extent of any disparities in BAME patients with CKD. Materials and Methods: PubMed, Embase (OVID), and CINAHL (EBSCO) databases were searched for relevant studies published between January 1, 2019, and November 24, 2023. Predetermined inclusion/exclusion criteria were utilized to shortlist abstracts. Two reviewers independently appraised articles and systematically extracted data and assessed the quality of studies. Thematic analysis was used for evidence synthesis; no quantitative meta-analysis was conducted. The review was registered with PROSPERO (CRD42020201771). Results: Two hundred and eleven abstracts were shortlisted, 52 articles were identified for full-text review, and 20 articles published worldwide were included in the final review. Themes identified included: effects of the COVID-19 pandemic on patients with CKD undergoing dialysis (six studies); impact on kidney transplant recipients and transplant programs (eight studies); and differential impact of COVID-19 on BAME patients in comparison with the general population (six studies). The presence of CKD in patients with COVID-19 was identified as a poor prognostic factor, along with obesity, lower socioeconomic status, and BAME population. Conclusion: The findings of this targeted review demonstrate the global impact of COVID-19 on various aspects of kidney replacement therapy and provide evidence of important disparities for BAME patients. In case of any future pandemic, vulnerable groups undergoing hemodialysis and those with kidney allografts will require special attention and care.

5 May 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HYHannah Young
Hannah Young
LALisa Ancliffe
Lisa Ancliffe
FCFfion Curtis
Ffion Curtis
Oluwafemi EfuntoyeOluwafemi Efuntoye
Oluwafemi Efuntoye
MGMatthew Pm Graham-Brown
Matthew Pm Graham-Brown
DMDaniel Scott March
Daniel Scott March
Chronic kidney disease (CKD) affects approximately 850 million people worldwide and is associated with a substantial and growing symptom burden. Fatigue is one of the most common and debilitating symptoms across all stages of CKD, with prevalence far exceeding that of the general population. It profoundly affects quality of life, daily functioning, and clinical outcomes, underscoring the need to identify and evaluate effective pharmacological and non-pharmacological strategies for its management. This protocol outlines methods for a systematic review to evaluate the efficacy, safety, and perceived effectiveness of interventions for fatigue in people with CKD. We will include randomised controlled trials, non-randomised controlled trials, before-and-after studies, and qualitative evaluations in adults and children with any stage of CKD. Searches will be conducted in MEDLINE, Embase, CINAHL, Web of Science Core Collection, PsycINFO, and ClinicalTrials.gov, alongside grey literature via Google Scholar. No language or publication date restrictions will be applied. Study selection will follow a two-stage screening process, with two reviewers independently assessing titles/abstracts and then full texts using predefined eligibility criteria. Data will be extracted using a standardised form, capturing study characteristics, interventions, and outcomes. Risk of bias will be assessed with the NIH Study Quality Assessment Tools or the Joanna Briggs Institute Critical Appraisal Checklist for Qualitative Research. Results will be synthesised narratively, and, where appropriate, pooled using meta-analysis. Certainty of the evidence for the primary outcome will be assessed using the GRADE approach and presented in a Summary of Findings table. This review will provide a comprehensive synthesis of evidence on interventions for fatigue in CKD, highlight gaps to guide future research, and inform the UK Kidney Association Symptom Guidelines.